Union is strength: antiviral and anti-inflammatory drugs for COVID-19
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference86 articles.
1. Emerging coronaviruses: genome structure, replication, and pathogenesis;Chen;J. Med. Virol.,2020
2. Real estimates of mortality following COVID-19 infection;Baud;Lancet Infect. Dis.,2020
3. The reproductive number of COVID-19 is higher compared to SARS coronavirus;Liu;J. Travel Med.,2020
4. Clinical, laboratory and imaging features of COVID-19: A systematic review and meta-analysis;Rodriguez-Morales;Travel Med. Infect. Dis.,2020
5. Presumed asymptomatic carrier transmission of COVID-19;Bai;JAMA,2020
Cited by 26 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Taming the storm: potential anti-inflammatory compounds targeting SARS-CoV-2 MPro;Inflammopharmacology;2024-07-24
2. RNAi-mediated inhibition of SARS-CoV-2: applications and challenges;Future Virology;2024-03-03
3. Synthesis, Characterization, and Molecular Docking of Casiopeinas® with Dipeptides as Secondary Ligand; Potential Inhibitors of SARS-Cov-2 Transcendental Proteins;Journal of the Mexican Chemical Society;2024-01-01
4. Wastewater surveillance of pharmaceuticals during the COVID-19 pandemic in Mexico City and the Mezquital Valley: A comprehensive environmental risk assessment;Science of The Total Environment;2023-11
5. Recent Developments in Semiconductor-Based Photocatalytic Degradation of Antiviral Drug Pollutants;Toxics;2023-08-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3